Riskpilot← Back to searchSign inGet full accessHISTOLAB PRODUCTS ApS
APSActiveCVR 28292090Bredgade 30Activities of agents involved in the wholesale of other particular products · NACE 4618Est. 20041 employees
Revenue 2025
DKK 14,9M
+2% vs 2024
EBITDA margin
0.7%
+1452% vs 2024
Equity ratio
74.6%
Financial strength
Net profit 2025
DKK 108K
+81% vs 2024
| Revenue | DKK 14,9M | +2% |
| EBITDA | DKK 97K | +1452% |
| Net profit | DKK 108K | +81% |
| Total assets | DKK 4,2M | +1% |
| Equity | DKK 3,1M | +4% |
| Employees | 1 | — |
Legal name
HISTOLAB PRODUCTS ApS
CVR number
28292090
Legal form
Anpartsselskab
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
30. november 2004
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af to medlemmer af bestyrelsen i forening eller af et medlem af bestyrelsen i forening med en direktør.
Company purpose
Selskabets formål er at importere, eksportere, producere hos underleverandører, lagerføre, engroshandel, agenturhandel og salg af diagnostiske produkter, ethanol, lægemidler, naturmedicin, næringsstoffer, kosmetiske produkter, sundhedsplejeprodukter og hospitalsudstyr- og materiel, såvel som at udføre tjenesteydelser i forbindelse hermed og i forbindelse med medicinsk videnskab, konsulentydelser, kursusvirksomhed og materieludlejning samt produktion af IT-programmer. Selskabet har endvidere til formål at eje og besidde fast ejendom og værdipapirer.
Address
Bredgade 30
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -8 | -17 | 387 | 999 | 6.629 | 7.413 | 8.210 | 8.484 | 12.265 | 13.442 | 13.109 | 14.982 | 14.577 | 14.889 |
| Staff expenses | -0 | -0 | -0 | -241 | -950 | -959 | -1.050 | -989 | -1.061 | -1.109 | -976 | -1.120 | -1.121 | -1.077 |
| EBITDA | -8 | -17 | 116 | 758 | 541 | 548 | 488 | 344 | 706 | 92 | 79 | 20 | -7 | 97 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -8 | -17 | 116 | 758 | 541 | 548 | 488 | 344 | 706 | 92 | 79 | 20 | -7 | 97 |
| Net financials | 0 | -0 | 0 | -2 | -4 | -10 | -2 | 2 | -3 | -7 | -3 | 67 | 85 | 42 |
| Profit before tax | -8 | -17 | 116 | 756 | 537 | 538 | 486 | 345 | 703 | 85 | 76 | 86 | 78 | 139 |
| Tax | -0 | -0 | 15 | 156 | 118 | 122 | 111 | 77 | 157 | 17 | 19 | 20 | 18 | 31 |
| Net profit | -8 | -17 | 101 | 600 | 419 | 415 | 375 | 269 | 546 | 68 | 57 | 66 | 59 | 108 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 73 | 58 | 316 | 1.635 | 2.322 | 2.656 | 3.021 | 3.355 | 5.315 | 5.403 | 4.349 | 4.203 | 4.164 | 4.196 |
| Equity | 63 | 46 | 147 | 748 | 1.166 | 1.582 | 1.957 | 2.225 | 2.771 | 2.839 | 2.896 | 2.963 | 3.022 | 3.130 |
| Long-term debt | 0 | 0 | 0 | 602 | 49 | 128 | 120 | 0 | 104 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 10 | 12 | 169 | 887 | 1.155 | 1.075 | 1.064 | 1.129 | 2.440 | 2.564 | 1.453 | 1.240 | 1.142 | 1.066 |
| Total debt | 10 | 12 | 169 | 887 | 1.155 | 1.075 | 1.064 | 1.129 | 2.544 | 2.564 | 1.453 | 1.240 | 1.142 | 1.066 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20122025
Equity ratio
74.6%
This company
38.2%
Market median
+95% vs market
20122025
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
20122025
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20122025
Asset turnover
3.55×
This company
1.12×
Market median
+217% vs market
20122025
Debt / equity
0.34×
This company
0.62×
Market median
+45% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TM Management | Management | 2010 | — | — |
JH Deputy | Deputy | 2017 | — | — |
AP Founder | Founder | 2004 | — | — |
CP Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
CC Management | Management | 2004 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2013 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2004 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2015 | — | — | |
| Chairman | 2019 | — | — | |
| Chairman | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of HISTOLAB PRODUCTS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Mikael Haglund | Management | 0 companies |
| Jan Håkan Svensson | Deputy | 0 companies |
| Algol Pharma OY | Founder | 0 companies |
| Caj Patrik Joakim Eurenius | Chief Executive Officer | 0 companies |
| Carl Christoffer Lindqvist | Management | 0 companies |
| Kim Niclas Rainer Willgren | Chairman | 0 companies |
| Thomas Ekström | Chairman | 0 companies |
| Terhi Saija Tuulevi Niva | Board of Directors | 0 companies |
| Johan Brage Wulff | Chairman | 0 companies |
| Frida Birgitta Ekstrand | Board of Directors | 0 companies |
| Carl Olof Jenefeldt | Chairman | 0 companies |
| Karl Joakim Alexander Flinck | Chairman | 0 companies |
| Heikki Juhani Haapoja | Chairman | 0 companies |